Adrenomedullin improves intestinal epithelial barrier function by downregulating myosin light chain phosphorylation in ulcerative colitis rats

Yi,Zaifeng; Fan,Heng; Liu,Xingxing; Tang,Qing; Zuo,Dongmei; Yang,Jia

doi:10.3892/mmr.2015.3887

Adrenomedullin improves intestinal epithelial barrier function by downregulating myosin light chain phosphorylation in ulcerative colitis rats

Authors:
- Zaifeng Yi
- Heng Fan
- Xingxing Liu
- Qing Tang
- Dongmei Zuo
- Jia Yang
View Affiliations

Affiliations: Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
Published online on: June 3, 2015 https://doi.org/10.3892/mmr.2015.3887
Pages: 3615-3620

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adrenomedullin (AM) is a pivotal endogenous vasoactive peptide, which can maintain epithelial barrier function in inflammatory bowel disease. Myosin light chain kinase (MLCK)‑dependent phosphorylated myosin light chain kinase (p‑MLC) is a key regulator of intestinal barrier function. The aim of the present study was to investigate the effect and mechanism of AM on the intestinal epithelial barrier in a rat model of ulcerative colitis (UC) induced by 2,4,6‑trinitro‑benzene‑sulfonic acid (TNBS). A total of 21 male Sprague‑Dawley rats were randomly divided into the following three groups and administered different agents for 7 days: The normal group (water and saline), model group (TNBS and saline) and the AM group (TNBS and AM; 1.0 µg). The weight of rats was recorded every day. Serum tumor necrosis factor‑α (TNF‑α) and interleukin‑6 (IL‑6) levels were detected using ELISA kits. Colon tissue was collected for the assessment of histological alterations. The protein expression of MLCK, p‑MLC and zonula occludens‑1 (ZO‑1) was examined by western blot analysis. Intestinal epithelial tight junctions were examined using transmission electron microscopy. The results demonstrated that in colitis model rats, the expression of TNF‑α, IL‑6, MLCK and p‑MLC significantly increased compared with normal rats. In addition, the expression of ZO‑1 decreased (P<0.05) and intestinal epithelial cell permeability increased. Following AM administration, TNF‑α, IL‑6, MLCK and p‑MLC expression significantly decreased compared with the model rats, the expression of ZO‑1 increased (P<0.05) and intestinal epithelial cell permeability reduced. These data indicate a protective effect of AM on intestinal epithelial barrier dysfunction via suppression of inflammatory cytokines and downregulation of MLCK‑p‑MLC in TNBS‑induced UC. In conclusion, AM/MLCK‑p‑MLC may be an important signaling pathway in the occurrence and development of UC.

View Figures

View References

1	Turner JR: Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 9:799–809. 2009. View Article : Google Scholar : PubMed/NCBI
2	Marchiando AM, Graham WV and Turner JR: Epithelial barriers in homeostasis and disease. Annu Rev Pathol. 5:119–144. 2010. View Article : Google Scholar : PubMed/NCBI
3	Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz KD and Binder V: Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut. 35:68–72. 1994. View Article : Google Scholar : PubMed/NCBI
4	Ashizuka S, Inagaki-Ohara K, Kuwasako K, Kato J, Inatsu H and Kitamura K: Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium. Microbiol Immunol. 53:573–581. 2009. View Article : Google Scholar : PubMed/NCBI
5	Gardiner KR, Anderson NH, Rowlands BJ and Barbul A: Colitis and colonic mucosal barrier dysfunction. Gut. 37:530–535. 1995. View Article : Google Scholar : PubMed/NCBI
6	Clayburgh DR, Shen L and Turner JR: A porous defense: The leaky epithelial barrier in intestinal disease. Lab Invest. 84:282–291. 2004. View Article : Google Scholar : PubMed/NCBI
7	Gibson PR: Increased gut permeability in Crohn's disease: Is TNF the link? Gut. 53:1724–1725. 2004. View Article : Google Scholar : PubMed/NCBI
8	Nusrat A, Turner JR and Madara JL: Molecular physiology and pathophysiology of tight junctions. IV Regulation of tight junctions by extracellular stimuli: Nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol. 279:G851–G857. 2000.PubMed/NCBI
9	Ye D, Ma I and Ma TY: Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol. 290:G496–G504. 2006. View Article : Google Scholar : PubMed/NCBI
10	Gu L, Li N, Gong J, Li Q, Zhu W and Li J: Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis. 203:1602–1612. 2011. View Article : Google Scholar : PubMed/NCBI
11	Costantini TW, Loomis WH, Putnam JG, et al: Pentoxifylline modulates intestinal tight junction signaling after burn injury: Effects on myosin light chain kinase. J Trauma. 66:17–24; discussion 24–25. 2009. View Article : Google Scholar : PubMed/NCBI
12	Shen L: Tight junctions on the move: Molecular mechanisms for epithelial barrier regulation. Ann NY Acad Sci. 1258:9–18. 2012. View Article : Google Scholar : PubMed/NCBI
13	Liu X, Xu J, Mei Q, Han L and Huang J: Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice. Dig Dis Sci. 58:107–114. 2013. View Article : Google Scholar
14	Elsasser TH and Kahl S: Adrenomedullin has multiple roles in disease stress: Development and remission of the inflammatory response. Microsc Res Tech. 57:120–129. 2002. View Article : Google Scholar : PubMed/NCBI
15	Sakata J, Asada Y, Shimokubo T, Kitani M, Inatsu H, Kitamura K, Kangawa K, Matsuo H, Sumiyoshi A and Eto T: Adrenomedullin in the gastrointestinal tract. Distribution and gene expression in rat and augmented gastric adrenomedullin after fasting. J Gastroenterol. 33:828–834. 1998. View Article : Google Scholar : PubMed/NCBI
16	Ashizuka S, Ishikawa N, Kato J, Yamaga J, Inatsu H, Eto T and Kitamura K: Effect of adrenomedullin administration on acetic acid-induced colitis in rats. Peptides. 26:2610–2615. 2005. View Article : Google Scholar : PubMed/NCBI
17	Kataoka Y, Miyazaki S, Yasuda S, Nagaya N, Noguchi T, Yamada N, Morii I, Kawamura A, Doi K, Miyatake K, et al: The first clinical pilot study of intravenous adrenomedullin administration in patients with acute myocardial infarction. J Cardiovasc Pharmacol. 56:413–419. 2010. View Article : Google Scholar : PubMed/NCBI
18	Gonzalez-Rey E, Fernandez-Martin A, Chorny A and Delgado M: Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease. Gut. 55:824–832. 2006. View Article : Google Scholar : PubMed/NCBI
19	Talero E, Alvarez de Sotomayor M, Sánchez-Fidalgo S and Motilva V: Vascular contribution of adrenomedullin to microcirculatory improvement in experimental colitis. Eur J Pharmacol. 670:601–607. 2011. View Article : Google Scholar : PubMed/NCBI
20	Hayashi Y, Narumi K, Tsuji S, Tsubokawa T, Nakaya MA, Wakayama T, Zuka M, Ohshima T, Yamagishi M and Okada T: Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: Insights from in vitro and in vivo experimental studies. Int J Colorectal Dis. 26:1453–1462. 2011. View Article : Google Scholar : PubMed/NCBI
21	Carrizo GJ, Wu R, Cui X, Dwivedi AJ, Simms HH and Wang P: Adrenomedullin and adrenomedullin-binding protein-1 down-regulate inflammatory cytokines and attenuate tissue injury after gut ischemia-reperfusion. Surgery. 141:245–253. 2007. View Article : Google Scholar : PubMed/NCBI
22	Zuo D, Liu X, Shou Z, Fan H, Tang Q, Duan X, Cao D, Zou Z and Zhang L: Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis. Int J Mol Med. 32:1337–1344. 2013.PubMed/NCBI
23	Li X, Wang Q, Xu H, Tao L, Lu J, Cai L and Wang C: Somatostatin regulates tight junction proteins expression in colitis mice. Int J Clin Exp Pathol. 7:2153–2162. 2014.PubMed/NCBI
24	Greig E and Sandle GI: Diarrhea in ulcerative colitis. The role of altered colonic sodium transport. Ann NY Acad Sci. 915:327–332. 2000. View Article : Google Scholar
25	Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO and Schulzke JD: Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 116:301–309. 1999. View Article : Google Scholar : PubMed/NCBI
26	Fischer A, Gluth M, Pape UF, Wiedenmann B, Theuring F and Baumgart DC: Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 304:G970–G979. 2013. View Article : Google Scholar : PubMed/NCBI
27	Ma TY, Boivin MA, Ye D, Pedram A and Said HM: Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: Role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol. 288:G422–G430. 2005. View Article : Google Scholar : PubMed/NCBI
28	Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR 2nd, Raleigh DR, Guan Y, Watson AJ, Montrose MH, et al: Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol. 189:111–126. 2010. View Article : Google Scholar : PubMed/NCBI
29	Sommer J, Engelowski E, Baran P, Garbers C, Floss DM and Scheller J: Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis. Int J Mol Med. 34:651–660. 2014.PubMed/NCBI
30	Irvine EJ and Marshall JK: Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology. 119:1740–1744. 2000. View Article : Google Scholar : PubMed/NCBI
31	Wyatt J, Vogelsang H, Hübl W, Waldhöer T and Lochs H: Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet. 341:1437–1439. 1993. View Article : Google Scholar : PubMed/NCBI
32	Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT and Turner JR: Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol. 166:409–419. 2005. View Article : Google Scholar : PubMed/NCBI
33	Taylor CT, Dzus AL and Colgan SP: Autocrine regulation of epithelial permeability by hypoxia: Role for polarized release of tumor necrosis factor alpha. Gastroenterology. 114:657–668. 1998. View Article : Google Scholar : PubMed/NCBI
34	Ueda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, Matsuo H, Fujimura Y, Yoshioka A, Masui K, et al: Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med. 160:132–136. 1999. View Article : Google Scholar : PubMed/NCBI
35	Higuchi S, Wu R, Zhou M, Marini CP, Ravikumar TS and Wang P: Gut hyperpermeability after ischemia and reperfusion: Attenuation with adrenomedullin and its binding protein treatment. Int J Clin Exp Pathol. 1:409–418. 2008.PubMed/NCBI